# N-Acetyl Cysteine (NAC / GlyNAC) - Clinical Longevity Review & Consensus Audit

> **Consensus Verdict**: N-Acetyl Cysteine (NAC) supplies the rate-limiting amino acid L-cysteine for de novo intracellular glutathione (GSH) biosynthesis. Seminal double-blind clinical trials (GlyNAC) demonstrate that 16 weeks of supplementation corrects severe age-associated glutathione deficiency (+121%), suppresses systemic inflammation (IL-6 -78%, TNF-alpha -54%, hs-CRP -47%), reverses lipid peroxidation (F2-isoprostanes -72%), restores mitochondrial fuel oxidation, and significantly enhances physical strength and 6-minute walk distance in older adults.

## 1. Executive Summary & Scores
- **Longevity Evidence Score**: **95/100**
- **Evidence Quality Tier**: **gold**
- **Human Clinical Evidence Strength**: 96/100
- **Primary Longevity Classification**: supplements
- **Safety Margin Score**: 94/100 (Higher is safer)
- **Time Burden**: ~1 minutes/day
- **Estimated Monthly Cost**: inexpensive
- **Adherence Friction**: 1/10 (Lower is easier to sustain)

---

## 2. Biological Mechanisms of Action
Provides the rate-limiting amino acid (cysteine) required for intracellular glutathione synthesis, acting as a powerful systemic antioxidant.

---

## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars)
- **Heart Health & Endothelial Function**: **82/100** [Rank #23 of 133 in Heart] - Effect: High (-87% Acute Renal Ischemic Injury in NEJM Double-Blind RCT)
    - Mechanism: Scavenges free radicals in microvascular beds, preventing ischemic renal injury, dampening oxidized LDL generation, and preserving endothelial vasodilation.
- **Brain Longevity & Neuroprotection**: **85/100** [Rank #28 of 141 in Brain] - Effect: High (Modulation of glial xCT cystine/glutamate antiporter in >1300 human subjects)
    - Mechanism: Drives the astrocyte cystine-glutamate exchanger, normalizing extrasynaptic glutamate tone, preventing excitotoxic neuronal apoptosis, and replenishing brain glutathione.
- **Metabolic Flexibility & Glycemic Control**: **84/100** [Rank #23 of 129 in Metabolic] - Effect: High (-44% HOMA-IR, +38% Mitochondrial ATP Synthesis)
    - Mechanism: Alleviates mitochondrial oxidative stress in skeletal muscle and hepatocytes, reversing lipid-induced insulin resistance and restoring normal fuel oxidation.
- **Cancer Defense & DNA Repair**: **74/100** [Rank #17 of 120 in Cancer Defense] - Effect: Moderate-High (Neutralizes electrophilic carcinogens and prevents DNA oxidative base modifications)
    - Mechanism: Directly conjugates with toxic electrophilic xenobiotics via glutathione S-transferase and prevents reactive oxygen-induced DNA strand breaks.
- **Endocrine & Anabolic Balance**: **0/100** [Rank #76 of 120 in Endocrine] - Effect: Neutral
    - Mechanism: Indirect testicular antioxidant defense with neutral direct androgen receptor binding.
- **Chronic Inflammation Reduction**: **93/100** [Rank #1 of 126 in Inflammation] - Effect: Very High (-78% IL-6, -54% TNF-a, -47% hs-CRP in Older Adults RCT)
    - Mechanism: Replenishes systemic and intracellular glutathione, neutralizing reactive oxygen species that activate NF-κB transcription and resolving chronic inflammaging.
- **Bone Density & Connective Matrix**: **48/100** [Rank #71 of 142 in Bone Matrix] - Effect: Mild (Dampens osteoclast RANKL-mediated oxidative activation)
    - Mechanism: Quenches reactive oxygen species essential for osteoclast differentiation and osteolytic bone resorption.
- **Cellular Longevity & Autophagy**: **92/100** [Rank #15 of 131 in Cellular] - Effect: Very High (+121% RBC Glutathione, -72% F2-Isoprostanes Lipid Peroxidation)
    - Mechanism: Provides bioavailable L-cysteine, the critical rate-limiting substrate for de novo synthesis of glutathione, restoring cellular redox equilibrium to youthful levels.

---

## 4. Practical Protocol & Administration Guidelines
- **Standard Clinical Dosage**: 600-1200mg
- **Recommended Timing**: Morning / Fasted
- **Administration Type**: supplement
- **Recommended Biomarkers to Monitor**: energy, soreness, cellular_longevity, brain_fog, bone_density, heart_health

---

## 5. Safety, Contraindications & Drug Interactions
- **Contraindications**: Concurrent use of nitroglycerin or organic nitrates without medical supervision (severe potentiated hypotension), Active cystinuria with cystine urolithiasis, Hypersensitivity to acetylcysteine
- **Safety Profile**: low_risk - Mild gastrointestinal upset or sulfurous reflux (mitigated by taking with meals); Transient nausea at doses exceeding 2,400 mg/day

---

## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs
1. **Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary supplementation with cysteine and glycine** [PMID: 21775557]
   - Link: https://pubmed.ncbi.nlm.nih.gov/21775557/
2. **GlyNAC Cognitive and Neuro-Oxidative Stress Improvement** [PMID: 33783471]
   - Link: https://pubmed.ncbi.nlm.nih.gov/33783471/
3. **Prevention of Radiocontrast-Agent-Induced Reductions in Renal Function by Acetylcysteine** [PMID: 10901274]
   - Link: https://pubmed.ncbi.nlm.nih.gov/10901274/
4. **Clinical trials of N-acetylcysteine in psychiatry and neurodegeneration: a systematic review** [PMID: 25857997]
   - Link: https://pubmed.ncbi.nlm.nih.gov/25857997/
5. **Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment: a double-blind trial** [PMID: 9230519]
   - Link: https://pubmed.ncbi.nlm.nih.gov/9230519/

---

## 7. Canonical Citation & Web Verification
- **Official Web Review**: [N-Acetyl Cysteine (NAC / GlyNAC) on LongevityReviews](https://longevityreviews.org/modalities/n_acetyl_cysteine_nac)
- **Last Evidence Calibration**: 2026-09-09
- **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.